Induction of tumor necrosis factor-α in solid tumor region by the orally administered synthetic muramyl dipeptide analogue, romurtide

International Immunopharmacology

Volumn 1, Issue 1, 2001, Pages 97-104

  Ueda, Hiroshi ^a   Yamazaki, Masatoshi ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Oral; Romurtide; Tumor necrosis factor

Indexed keywords

MURAMYL DIPEPTIDE DERIVATIVE; MUROCTASIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DRUG EFFECT; HOST RESISTANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SOLID TUMOR;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; INJECTIONS, INTRAVENOUS; LIVER; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; MICE, INBRED ICR; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035129881     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(00)00017-5     Document Type: Article

References (37)

1. Muramyl peptides, chemical structure, biological activity and mechanism of action
2. Augmentation of immune responses by a muramyl dipeptide analog, MDP-Lys(L18)
3. Adjuvant activity of mycobacterial fractions: Adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds
4. Review: Inducer of cytokines in vivo: Overview of field and romurtide experience
5. Development of the cytokine inducer romurtide: Experimental studies and clinical application
6. An endotoxin-induced serum factor that causes necrosis of tumors
7. Modulation of the immune response by a synthetic adjuvant and analogs
8. Minimal structural requirement for adjuvant activity of bacterial peptidoglycan derivatives
9. Stimulation of complement production in mice by N alpha-(N-acetylmuramyl-L-alanyl-D-isoglutamine)-N epsilon-stearoyl-L-lysine
10. Stimulation of plasma fibronectin production in mice by muroctasin
11. Effect of MDP-Lys(L18) as a mucosal immunoadjuvant on protection of mucosal infections by Sendai virus and rotavirus
12. Enhancement by muramyldipeptides of the activities of early-type inducers of interferon
13. Immunoadjuvant activities of peptidoglycan subsets from the cell walls of Staphylococcus aureus and Lactobacillus plantarum
14. In vitro regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyldipeptide for MDP
15. The origin and function of tumor-associated macrophages
16. Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice
17. Phenotype and functions of intratumoral macrophages
18. Significance of endogenous production of TNF
19. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma
20. Beneficial effect of muroctasin on experimental leukopenia induced by cyclophosphamide or irradiation in mice
21. Oral application of romurtide, a synthetic muramyl dipeptide derivative, stimulates nonspecific resistance to microbial infections and hematopoiesis in mice
22. Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor
23. 14C-muroctasin in laboratory animals
24. Acute toxicity of muroctasin in mice, rats and dogs
25. Polymorphonuclear leukocyte activation by a synthetic muramyl dipeptide analog
26. Synergistic activation by recombinant mouse interferon-γ and muramyl dipeptide of tumoricidal properties in mouse macrophages
27. Production of interleukin-6 from macrophages by MDP-Lys (L 18), romurtide
28. Muroctasin [MDP-Lys(18)] augments the production of granulocyte colony-stimulating factor (G-CSF) from human peripheral blood mononuclear cells in vitro
29. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages
30. Inflammatory cytokine production induced by an analogue of muramyl dipeptide MDP-Lys(L18) in rat macrophage cultures and dog synovial fluid
31. Tumor necrosis factor, other cytokines and disease
32. Restorative activity of muroctasin on leukopenia associated with anticancer treatment
33. Priming effect of orally administered synthetic MDP analogue (Romurtide) on induction of tumor necrosis factor
34. Induction of tumor necrosis factor in a murine tumor by systemic administration of a novel synthetic lipid A analogue, ONO-4007
35. Induction of colony-stimulating factor and stimulation of stem cell proliferation by injection of muroctasin
36. Augmentation of release of cytotoxin from murine bone marrow and peritoneal macrophages by tumor transplantation
37. MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumours in mice